SearchDictionaryMobileLogin

Periodontal Diseases (Periodontal Disease)

3754  relevant articles (98 outcomes, 562 trials/studies) found for this Disease

Description: Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.

Also Known As:
Periodontal Disease; Disease, Periodontal; Diseases, Periodontal; Parodontoses; Parodontosis; Pyorrhea Alveolaris

Relationship Network

Disease Context: Research Results

Related Diseases

1. Dental Caries (White Spot)
2. Periodontitis
3. Gingivitis
4. Bone Resorption
5. Hemorrhage

Experts

1. Seymour, G J: 7 articles (06/2008 - 06/2001)
2. Kocher, T: 5 articles (06/2005 - 08/2000)
3. Meisel, P: 5 articles (02/2004 - 08/2001)
4. Giannobile, William V: 4 articles (08/2008 - 01/2003)
5. Emingil, G: 4 articles (03/2008 - 08/2001)
6. Atilla, Gül: 4 articles (09/2006 - 08/2005)
7. Emingil, Gülnur: 4 articles (09/2006 - 08/2005)
8. Van Dyke, Thomas E: 4 articles (10/2005 - 06/2002)
9. Breivik, Torbjørn: 4 articles (08/2005 - 11/2003)
10. Buduneli, Nurcan: 3 articles (07/2008 - 04/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Periodontal Diseases:
1. Metronidazole (Metric)FDA LinkGeneric
2. Tetracycline (Achromycin)FDA LinkGeneric
3. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
4. TetracyclinesIBA
5. ToothpasteIBA
6. CollagenIBA
7. Anti-Bacterial Agents (Antibiotics)IBA
8. FluoridesIBA
9. Triclosan (pHisoHex)FDA Link
10. Interferon-gamma (Interferon, gamma)IBA
11/01/2003 - "The purpose of this study was to investigate the associations between gingival crevicular fluid interferon gamma (GCF IFN-gamma) and clinical measures of periodontal disease in HIV+ individuals. "
06/01/2005 - "In contrast to the inhibitory effect of gamma interferon (IFN-gamma) on RANKL-mediated osteoclastogenesis reported recently, alternative new evidence is demonstrated via studies of experimental periodontitis using humanized NOD/SCID and diabetic NOD mice and clinical human T-cell isolates from diseased periodontal tissues, where the presence of increasing IFN-gamma is clearly associated with (i) enhanced Actinobacillus actinomycetemcomitans-specific RANKL-expressing CD4(+) Th cell-mediated alveolar bone loss during the progression of periodontal disease and (ii) a concomitant and significantly increased coexpression of IFN-gamma in RANKL(+) CD4(+) Th cells. "
08/01/2002 - "In contrast, SHAM treatment caused high plasma interferon-gamma cytokine levels and protective effects in periodontal disease. "
02/01/2008 - "RESULTS: Our results showed no significant difference in the allele and genotype frequencies of interleukin-4 (C-590T) and interferon-gamma (G5644A) gene polymorphisms between patients with periodontal disease and controls. "
04/01/1992 - "A group of factors which are negative regulators of inflammation including TGF-beta, gamma-interferon, and IL-1 receptor antagonist provide potential for assessment of periodontal disease in remission or in the healing phase. "
Order ALL the reference details at left...

Therapies and Procedures

1. Oral Hygiene (Dental Hygiene)
2. Root Planing
3. Drug Therapy (Chemotherapy)
4. Ligation
5. Dental Care

Best Treatments:
Research Summary Report
on Periodontal Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 98 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>